Technology empowers innovation, and Ruihe Pharmaceutical's Shugan Ning injection has been listed on the 2024 annual patent-intensive product list.

       On February 8, 2025, the China Patent Protection Association officially announced the results of the 2024 annual identification of patent-intensive products, with a total of 3,197 products successfully selected. Guizhou Ruihe Pharmaceutical Co., Ltd.'s Shugan Ning injection, with its outstanding patent technology strength and market competitiveness, made the list, showcasing the company's deep accumulation and practical achievements in patent innovation and industrial application.

       This identification work is based on the "Evaluation Method for Patent-Intensive Products of Enterprises" (T/PPAC402-2022), and after strict declaration, review, identification, and public announcement processes, representative products with high-value patent layout, technological innovation advantages, and industrial application effectiveness were finally selected. Shugan Ning injection stood out among many declared products due to its solid patent system, continuous technological innovation, and extensive clinical recognition.

       As an important product of Ruihe Pharmaceutical in the field of liver disease, Shugan Ning injection integrates the essence of traditional Chinese medicine with modern pharmaceutical technology, possessing the ability to clear heat and detoxify,Shugan Liqihas significant therapeutic effects. The product has not only obtained multiple patent authorizations but has also achieved excellent results in the transformation of patent achievements and market applications. This identification further highlights Ruihe Pharmaceutical's firm steps on the path of pharmaceutical innovation, promoting the company towards a more specialized and technological direction.

      In the future, Ruihe Pharmaceutical will continue to deepen technological innovation, accelerate the industrialization of patent achievements, continuously provide health products and services for humanity, assist the pharmaceutical industry in high-quality development, and strive to become a first-class enterprise that satisfies customers and earns respect from society.